top of page
  • Writer's pictureWest Island News

AstraZeneca Admits Rare Blood Clot Risk from COVID Vaccines 🚨


AstraZeneca, the British drugmaker behind one of the world's most widely used COVID vaccines, has admitted that there's a risk of blood clots associated with its jab. However, the company stressed that these cases are "extremely rare."

More than 50 cases of blood clots have been reported in the UK among patients who received vaccines produced by the Serum Institute of India, a manufacturer for AstraZeneca. Despite this, regulators worldwide maintain that the benefits of vaccination far outweigh the risks of these rare side effects.

In light of recent events, AstraZeneca is facing a class action lawsuit in the UK, with victims seeking damages of up to £100 million. The lawsuit alleges that the vaccine caused fatalities and severe injuries in numerous cases.

The vaccine, known under various names including Covishield in India, was developed in the UK and produced by SII in India, with distribution worldwide.

AstraZeneca has expressed sympathy for those affected by adverse reactions to its vaccine. Stay tuned for further updates on this developing story. #COVID19 #AstraZeneca #VaccineSafety

Comments


bottom of page